An accelerated pathway for targeted cancer therapies.

Published

Journal Article

A well-defined pathway for the accelerated development and approval of targeted cancer therapies and companion diagnostics would reduce uncertainty, improve efficiency in development and provide an effective incentive for developers.

Full Text

Duke Authors

Cited Authors

  • McClellan, M; Benner, J; Schilsky, R; Epstein, D; Woosley, R; Friend, S; Sidransky, D; Geoghegan, C; Kessler, D

Published Date

  • February 2011

Published In

Volume / Issue

  • 10 / 2

Start / End Page

  • 79 - 80

PubMed ID

  • 21283090

Pubmed Central ID

  • 21283090

Electronic International Standard Serial Number (EISSN)

  • 1474-1784

International Standard Serial Number (ISSN)

  • 1474-1776

Digital Object Identifier (DOI)

  • 10.1038/nrd3360

Language

  • eng